Literature DB >> 2090950

A presynaptic excitatory M1 muscarine receptor at postganglionic cardiac noradrenergic nerve fibres that is activated by endogenous acetylcholine.

A Habermeier-Muth1, U Altes, K M Forsyth, E Muscholl.   

Abstract

Rabbit atria were isolated with the extrinsic right vagus and sympathetic nerves intact and perfused with Tyrode solution. Noradrenaline overflow evoked by sympathetic nerve stimulation (SNS) at 3 Hz for 3 min was determined before, during, and after vagus nerve stimulation (VNS), also at 3 Hz and for 3 min. The VNS pulses preceded the SNS pulses by 3, 100 and 233 ms. Acetylcholine overflow was determined after labelling of the transmitter stores with [14C]choline. Pirenzepine 80 nmol/l failed to alter the muscarinic inhibition of noradrenaline overflow when the vago-sympathetic impulse intervals were 3 and 233 ms. At an interval of 100 ms VNS did not significantly inhibit noradrenaline overflow in the absence of pirenzepine but produced an inhibition in the presence of the drug. When the pirenzepine concentration was varied (0.4-300 nmol/l) the largest inhibition of noradrenaline overflow was observed at 5.7 nmol/l whereas 300 nmol/l fully antagonized the inhibition. Acetylcholine overflow evoked by VNS was not altered by pirenzepine 0.4-300 nmol/l. AF-DX 116 (11-[(2[(diethylamino)methyl]-1-piperidinyl)-acetyl]-5, 11-dihydro-6H-pyrido-[2,3-b]-[1,4]benzodiazepine-6-one), an M2 receptor selective antagonist, concentration-dependently (100-800 nmol/l) inhibited the decrease of tension development elicited by VNS. At the 100 ms vago-sympathetic impulse interval noradrenaline overflow was enhanced in the presence of AF-DX 116 400 and 800 nmol/l. However, already 100 nmol/l of the drug caused a maximum (fourfold) increase of acetylcholine overflow. It is concluded that acetylcholine released onto noradrenergic nerve fibres causes a small facilitation of noradrenaline overflow at a vago-sympathetic impulse interval of 100 ms.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2090950     DOI: 10.1007/BF00169033

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  15 in total

1.  Pharmacological distinction between two muscarinic responses on the isolated superior cervical ganglion of the rat.

Authors:  N R Newberry; T Priestley; G N Woodruff
Journal:  Eur J Pharmacol       Date:  1985-10-08       Impact factor: 4.432

2.  Inhibition by parasympathetic nerve stimulation of the release of the adrenergic transmitter.

Authors:  K Löffelholz; E Muscholl
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1970

3.  AF-DX 116, a cardioselective muscarinic antagonist.

Authors:  R Micheletti; E Montagna; A Giachetti
Journal:  J Pharmacol Exp Ther       Date:  1987-05       Impact factor: 4.030

4.  Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterization.

Authors:  R Hammer; A Giachetti
Journal:  Life Sci       Date:  1982-12-27       Impact factor: 5.037

5.  Short- and long-latency muscarinic inhibition of noradrenaline release from rabbit atria induced by vagal stimulation.

Authors:  A Habermeier-Muth; E Muscholl
Journal:  J Physiol       Date:  1988-07       Impact factor: 5.182

6.  M2 muscarinic receptors on the iris sphincter muscle differ from those on iris noradrenergic nerves.

Authors:  I T Bognar; B Baumann; F Dammann; B Knöll; M Meincke; S Pallas; H Fuder
Journal:  Eur J Pharmacol       Date:  1989-04-25       Impact factor: 4.432

7.  Differential and selective antagonism of the slow-inhibitory postsynaptic potential and slow-excitatory postsynaptic potential by gallamine and pirenzepine in the superior cervical ganglion of the rabbit.

Authors:  J H Ashe; C A Yarosh
Journal:  Neuropharmacology       Date:  1984-11       Impact factor: 5.250

8.  AF-DX 116: a selective antagonist of the slow inhibitory postsynaptic potential and methacholine-induced hyperpolarization in superior cervical ganglion of the rabbit.

Authors:  C A Yarosh; A C Olito; J H Ashe
Journal:  J Pharmacol Exp Ther       Date:  1988-05       Impact factor: 4.030

9.  The effect of physostigmine on the vagally induced muscarinic inhibition of noradrenaline release from the isolated perfused rabbit atria.

Authors:  E Muscholl; A Muth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-08       Impact factor: 3.000

10.  Sympathetic Nerve Stimulation on the perfused rat heart. Affinities of N-methylatropine and pirenzepine at pre- and postsynaptic muscarine receptors.

Authors:  H Fuder; D Rink; E Muscholl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-02       Impact factor: 3.000

View more
  8 in total

1.  Cardiac muscarinic receptors decrease with age. In vitro and in vivo studies.

Authors:  O E Brodde; U Konschak; K Becker; F Rüter; U Poller; J Jakubetz; J Radke; H R Zerkowski
Journal:  J Clin Invest       Date:  1998-01-15       Impact factor: 14.808

2.  Prejunctional muscarine receptors in the rabbit ear artery differ from M1, M2 and M3 muscarine receptors.

Authors:  S A Darroch; L K Choo; F Mitchelson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-03       Impact factor: 3.000

3.  Evidence that M1 muscarinic receptors enhance noradrenaline release in mouse atria by activating protein kinase C.

Authors:  M Costa; M Barrington; H Majewski
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

4.  Evidence for M1 muscarinic cholinoceptors mediating facilitation of noradrenaline release in guinea-pig carotid artery.

Authors:  M A Casado; J Marín; M Salaices
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-10       Impact factor: 3.000

5.  Heterogeneity of presynaptic muscarinic receptors mediating inhibition of sympathetic transmitter release: a study with M2- and M4-receptor-deficient mice.

Authors:  Anne-Ulrike Trendelenburg; Jesus Gomeza; Werner Klebroff; Hongxia Zhou; Jürgen Wess
Journal:  Br J Pharmacol       Date:  2003-02       Impact factor: 8.739

6.  Characterization of the prejunctional muscarinic receptors mediating inhibition of evoked release of endogenous noradrenaline in rabbit isolated vas deferens.

Authors:  U Grimm; H Fuder; U Moser; H G Bümert; E Mutschler; G Lambrecht
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-01       Impact factor: 3.000

Review 7.  Cholinergic activity as a new target in diseases of the heart.

Authors:  Ashbeel Roy; Silvia Guatimosim; Vania F Prado; Robert Gros; Marco A M Prado
Journal:  Mol Med       Date:  2015-01-26       Impact factor: 6.354

8.  Impulse interval-dependent effect of sympathetic nerve stimulation on evoked acetylcholine release from the rabbit perfused atria preparation.

Authors:  A Habermeier-Muth; E Muscholl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-02       Impact factor: 3.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.